Tectonic Therapeutic (TECX) News Today $40.45 -2.81 (-6.50%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst UpgradeNovember 14 at 1:17 AM | americanbankingnews.comTectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year High on Analyst UpgradeTectonic Therapeutic (NASDAQ:TECX) Sets New 12-Month High Following Analyst UpgradeNovember 13, 2024 | marketbeat.comLeerink Partners Forecasts Strong Price Appreciation for Tectonic Therapeutic (NASDAQ:TECX) StockNovember 13, 2024 | americanbankingnews.comTectonic Therapeutic (NASDAQ:TECX) is BML Capital Management LLC's 7th Largest PositionBML Capital Management LLC lowered its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 54.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 211,752 shares of the company's stock after selling 254,295 shares during the peNovember 12, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up on Analyst UpgradeTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst UpgradeNovember 12, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $79.00Wells Fargo & Company boosted their price objective on shares of Tectonic Therapeutic from $55.00 to $79.00 and gave the company an "overweight" rating in a research note on Tuesday.November 12, 2024 | marketbeat.comTectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion ProteinNovember 11, 2024 | globenewswire.comCritical Analysis: Tectonic Therapeutic (NASDAQ:TECX) & Vitro Diagnostics (OTCMKTS:VODG)November 11, 2024 | americanbankingnews.comInsiders Pour Million-Plus Dollars into These 2 Stocks — Here’s Why You Should Take NoticeNovember 8, 2024 | msn.comTectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - What's Next?November 7, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - Here's What HappenedNovember 1, 2024 | marketbeat.comTectonic Therapeutic Independent Director Acquires 7.0% More StockOctober 29, 2024 | finance.yahoo.comInsider Purchase: Director at Tectonic Therapeutic (TECX) Buys 300,000 SharesOctober 25, 2024 | quiverquant.comTectonic Therapeutic (NASDAQ:TECX) Sets New 12-Month High After Insider Buying ActivityTectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High on Insider Buying ActivityOctober 25, 2024 | marketbeat.comInsider Buying: Tectonic Therapeutic (NASDAQ:TECX) Director Purchases 300,000 Shares of StockOctober 25, 2024 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in StockTectonic Therapeutic (NASDAQ:TECX - Get Free Report) Director Timothy A. Springer purchased 300,000 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were acquired at an average price of $33.59 per share, for a total transaction of $10,077,000.00. Following the completion of the transaction, the director now directly owns 4,096,764 shares of the company's stock, valued at $137,610,302.76. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.October 24, 2024 | marketbeat.comTectonic Therapeutic to Present Phase 1a Data at AHA 2024October 22, 2024 | globenewswire.comTectonic Therapeutic: Interesting CV Disease Drug DeveloperOctober 20, 2024 | seekingalpha.comTectonic Therapeutic, Inc. (TECX)October 20, 2024 | finance.yahoo.comTectonic Therapeutic (NASDAQ:TECX) Reaches New 1-Year High - Time to Buy?Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week High - Here's WhyOctober 15, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sees Unusually-High Trading Volume - Still a Buy?Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - Here's What HappenedOctober 14, 2024 | marketbeat.comShort Interest in Tectonic Therapeutic (NASDAQ:TECX) Increases By 258.0%Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 303,900 shares, an increase of 258.0% from the September 15th total of 84,900 shares. Approximately 3.9% of the shares of the stock are sold short. Based on an average trading volume of 72,400 shares, the short-interest ratio is presently 4.2 days.October 10, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Down 4.5% - Time to Sell?Tectonic Therapeutic (NASDAQ:TECX) Trading Down 4.5% - Here's WhyOctober 9, 2024 | marketbeat.comVida Ventures Advisors LLC Takes Position in Tectonic Therapeutic (NASDAQ:TECX)Vida Ventures Advisors LLC bought a new stake in Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,028,674 shares of the company's stock, valued at approximOctober 9, 2024 | marketbeat.com89,029 Shares in Tectonic Therapeutic (NASDAQ:TECX) Acquired by Renaissance Technologies LLCRenaissance Technologies LLC purchased a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 89,029 shares of the company's stock, valued atOctober 5, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year High - What's Next?October 4, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Up 5.8%Tectonic Therapeutic (NASDAQ:TECX) Shares Up 5.8%October 2, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Trading Down 7%Tectonic Therapeutic (NASDAQ:TECX) Trading Down 7%October 1, 2024 | marketbeat.comTectonic Therapeutic director buys shares worth over $1.4 millionSeptember 28, 2024 | investing.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $1,441,000.00 in StockSeptember 27, 2024 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Short Interest UpdateTectonic Therapeutic (NASDAQ:TECX - Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 84,900 shares, a growth of 166.1% from the August 31st total of 31,900 shares. Approximately 0.7% of the shares of the stock are short sold. Based on an average trading volume of 47,000 shares, the short-interest ratio is presently 1.8 days.September 26, 2024 | marketbeat.comAffinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX)Affinity Asset Advisors LLC purchased a new stake in Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 58,331 shares of the company's stock, valued at approximateSeptember 25, 2024 | marketbeat.comFarallon Capital Management LLC Makes New $7.10 Million Investment in Tectonic Therapeutic (NASDAQ:TECX)Farallon Capital Management LLC purchased a new position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 431,010 shares of the company's stock, valued at approxSeptember 24, 2024 | marketbeat.comNxera Pharma Co., Ltd. (4565.T) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comTectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth PlansSeptember 23, 2024 | finance.yahoo.comTD Cowen Reaffirms Their Buy Rating on Tectonic Therapeutic (TECX)September 21, 2024 | markets.businessinsider.comPiper Sandler Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)September 21, 2024 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Sees Large Volume IncreaseTectonic Therapeutic (NASDAQ:TECX) Sees Strong Trading VolumeSeptember 20, 2024 | marketbeat.comTectonic Therapeutics Announces Positive Phase 1a Results For TX45 In Treating Group 2 PH-HFpEFSeptember 20, 2024 | markets.businessinsider.comTectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45September 19, 2024 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9%Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9%September 17, 2024 | marketbeat.comAtlas Venture Life Science Advisors LLC Buys New Stake in Tectonic Therapeutic (NASDAQ:TECX)Atlas Venture Life Science Advisors LLC purchased a new position in Tectonic Therapeutic (NASDAQ:TECX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 378,447 shares of the company's stock, valuSeptember 15, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Short Interest Up 52.6% in AugustTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totalling 31,900 shares, an increase of 52.6% from the August 15th total of 20,900 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 26,700 shares, the days-to-cover ratio is currently 1.2 days.September 13, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $17.50Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $17.50September 12, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Shares Down 2.9% Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 2.9%September 4, 2024 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sees Large Growth in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 20,900 shares, an increase of 50.4% from the July 31st total of 13,900 shares. Based on an average daily trading volume, of 26,700 shares, the short-interest ratio is currently 0.8 days. Approximately 0.2% of the company's shares are sold short.August 29, 2024 | marketbeat.comWells Fargo Initiates Coverage of Tectonic Therapeutic (TECX) with Overweight RecommendationAugust 24, 2024 | msn.comTECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024August 24, 2024 | investorplace.comPromising Outlook for Tectonic Therapeutics’ Novel Drug TX45 in Treating PH-LHDAugust 22, 2024 | markets.businessinsider.comTectonic draws bullish view at Wells Fargo on lead assetAugust 22, 2024 | msn.com Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. TECX Media Mentions By Week TECX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECX News Sentiment▼0.940.56▲Average Medical News Sentiment TECX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECX Articles This Week▼113▲TECX Articles Average Week Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Keros Therapeutics News Today SpringWorks Therapeutics News Today Akero Therapeutics News Today Amphastar Pharmaceuticals News Today Scholar Rock News Today Longboard Pharmaceuticals News Today NewAmsterdam Pharma News Today Harmony Biosciences News Today Wave Life Sciences News Today Spyre Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
